Alcon AG (ALC)vsRepligen Corporation (RGEN)
ALC
Alcon AG
$75.26
+1.37%
HEALTHCARE · Cap: $37.11B
RGEN
Repligen Corporation
$114.32
-1.70%
HEALTHCARE · Cap: $6.55B
Smart Verdict
WallStSmart Research — data-driven comparison
Alcon AG generates 1309% more annual revenue ($10.40B vs $738.26M). ALC leads profitability with a 9.4% profit margin vs 6.6%. ALC appears more attractively valued with a PEG of 1.70. ALC earns a higher WallStSmart Score of 49/100 (D+).
ALC
Hold49
out of 100
Grade: D+
RGEN
Hold45
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-489.8%
Fair Value
$13.46
Current Price
$75.26
$61.80 premium
Margin of Safety
-246.3%
Fair Value
$40.25
Current Price
$114.32
$74.07 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Reasonable price relative to book value
18.1% revenue growth
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
ROE of 4.5% — below average capital efficiency
Earnings declined 22.2%
1.6% earnings growth
ROE of 2.4% — below average capital efficiency
6.6% margin — thin
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : ALC
The strongest argument for ALC centers on Debt/Equity, Price/Book.
Bull Case : RGEN
The strongest argument for RGEN centers on Revenue Growth. Revenue growth of 18.1% demonstrates continued momentum.
Bear Case : ALC
The primary concerns for ALC are PEG Ratio, P/E Ratio, Return on Equity.
Bear Case : RGEN
The primary concerns for RGEN are EPS Growth, Return on Equity, Profit Margin. A P/E of 135.2x leaves little room for execution misses.
Key Dynamics to Monitor
ALC profiles as a value stock while RGEN is a growth play — different risk/reward profiles.
RGEN carries more volatility with a beta of 1.18 — expect wider price swings.
RGEN is growing revenue faster at 18.1% — sustainability is the question.
ALC generates stronger free cash flow (489M), providing more financial flexibility.
Bottom Line
ALC scores higher overall (49/100 vs 45/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Alcon AG
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.
Visit Website →Repligen Corporation
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?